Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2021-03-24FDA Approved: ISTODAX — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for Istodax (romidepsin) to update its labeling, likely reflecting a new indication, safety, or othe…